Granting Stock Acquisition Rights to Directors, Executive Officers and Employees
First written in FY2021. 6 of 8 entries say "Advanced", first in FY2022-Q1. Latest entry: FY2026.
106 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The decrease in treasury shares was due to the disposal of 276,200 treasury shares upon the exercise of stock options and the disposal of 185,700 treasury shares through a third-party allotment.」
Under the existing stock acquisition rights program, 276,200 shares were exercised during the current fiscal year. This was an increase from the 20,200 shares exercised in the previous fiscal year. - FY2025AdvancedAnnual report
「The decrease in treasury shares was due to a decrease of 20,200 shares resulting from the exercise of stock options.」
Under the existing stock acquisition rights program, 20,200 shares were exercised during the current fiscal year. - FY2023-Q3AdvancedAnnual report
「In connection with this stock split, the exercise price per share of the stock acquisition rights issued by the Company will be adjusted as follows from 1 April 2023. Eighth Series of Stock Acquisition Rights ¥2,389 ¥1,195 Ninth Series of Stock Acquisition Rights ¥3,917 ¥1,959」
In connection with the stock split, the exercise prices per share for the Eighth and Ninth Series of Stock Acquisition Rights were specifically adjusted. - FY2023-Q2RestatedAnnual report
「Number of stock acquisition rights (rights)* 2,820 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 282,000 (Note 1) Amount payable upon exercise of the stock acquisition rights (yen)* 3,917 (Note 1) Exercise period for the stock acquisition rights* From 18 June 2024 to 17 June 2032 (Note 2)」
The disclosed terms for the Ninth Series of Stock Acquisition Rights continue to include 2,820 rights covering 282,000 shares, an exercise price of ¥3,917 per share and an exercise period from 18 June 2024 to 17 June 2032. - FY2023-Q1AdvancedAnnual report
「Based on a resolution of the Board of Directors dated 17 June 2022, the Company issued stock acquisition rights on particularly favorable terms as stock options to directors of its subsidiaries, as well as executive officers and employees of the Company and its subsidiaries. The previously undetermined terms of the issue were finalized on 4 July 2022.」
The issue terms for the Ninth Series of Stock Acquisition Rights were finalized, including 2,820 rights covering 282,000 shares, an exercise price of ¥3,917 per share and an exercise period from 18 June 2024 to 17 June 2032. - FY2022AdvancedAnnual report
「Number of stock acquisition rights (rights)* 3,415 (Note 2) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 341,500 (Note 2) Exercise period for the stock acquisition rights* From 18 June 2023 to 17 June 2031 (Note 5)」
For the stock acquisition rights whose grant policy was announced in the previous fiscal year, the remaining balance after forfeitures was specified as 3,415 rights covering 341,500 shares. Approval to issue 4,000 rights covering 400,000 shares as the Ninth Series of Stock Acquisition Rights was also disclosed. - FY2022-Q1AdvancedAnnual report
「Number of stock acquisition rights (rights)* 3,455 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 345,500 (Note 1) Exercise period for the stock acquisition rights* From 18 June 2023 to 17 June 2031 (Note 2)」
Specific terms were disclosed for the stock acquisition rights whose grant had been proposed in the previous fiscal year, including 3,455 rights covering 345,500 shares and an exercise period from 18 June 2023 to 17 June 2031. - FY2021First statedAnnual report
「At a meeting of the Board of Directors held on 19 May 2021, the company resolved to submit to the 54th Annual General Meeting of Shareholders held on 17 June 2021 a proposal seeking approval to issue stock acquisition rights free of charge as stock options to directors of the company and its subsidiaries, excluding outside directors, as well as executive officers and employees, pursuant to the Companies Act, and to delegate authority to determine the offering terms to the company's Board of Directors. The proposal was approved at the meeting.」
A policy was approved to grant, free of charge, up to 3,455 stock acquisition rights covering 345,500 shares, with the aim of sharing the benefits and risks of share-price movements with shareholders and increasing motivation to improve business performance.